3E0R3CZ Introduction of Regional Anesthetic into Spinal Canal, Percutaneous Approach...
ICD-10-PCS Procedure Codes
WARNING: Code Deleted 2017-09-30
3E0R3CZ - Introduction of Regional Anesthetic into Spinal Canal, Percutaneous ApproachThe above description is abbreviated. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. Access to this feature is available in the following products:
The above description is abbreviated. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. |
(Code structure information is unavailable due to the code having been deleted.)
3E0 Section Table
| Body System / Region | Approach | Substance | Qualifier |
|---|---|---|---|
| 0 Skin and Mucous Membranes | X External | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| 0 Skin and Mucous Membranes | X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| 0 Skin and Mucous Membranes | X External | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine B Anesthetic Agent K Other Diagnostic Substance M Pigment N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 0 Skin and Mucous Membranes | X External | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| 1 Subcutaneous Tissue | 0 Open | 2 Anti-infective | A Anti-Infective Envelope |
| Body System / Region | Approach | Substance | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective A Anti-Infective Envelope |
| Body System / Region | Approach | Substance | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | 4 Serum, Toxoid and Vaccine | 0 Autologous Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| 1 Subcutaneous Tissue | 3 Percutaneous | V Hormone | G Insulin J Other Hormone |
| Body System / Region | Approach | Substance | Qualifier |
| 2 Muscle | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| 2 Muscle | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| 2 Muscle | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 2 Muscle | 3 Percutaneous | 4 Serum, Toxoid and Vaccine | 0 Autologous Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 2 Muscle | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 0 Open | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 0 Open | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 0 Open | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 0 Open | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 0 Open | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 0 Open | U Pancreatic Islet Cells | 0 Autologous 1 Nonautologous |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 0 Open | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 0 Open | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance A Stem Cells, Embryonic F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption Q Glucarpidase R Other Therapeutic Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | U Pancreatic Islet Cells | 0 Autologous 1 Nonautologous |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region | Approach | Substance | Qualifier |
| 3 Peripheral Vein | 3 Percutaneous | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 0 Open | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 0 Open | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 0 Open | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 0 Open | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 0 Open | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 0 Open | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 0 Open | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 3 Percutaneous | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 3 Percutaneous | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance A Stem Cells, Embryonic F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption Q Glucarpidase R Other Therapeutic Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 3 Percutaneous | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region | Approach | Substance | Qualifier |
| 4 Central Vein | 3 Percutaneous | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| Body System / Region | Approach | Substance | Qualifier |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region | Approach | Substance | Qualifier |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region | Approach | Substance | Qualifier |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | G Other Therapeutic Substance | C Other Substance N Blood Brain Barrier Disruption |
| Body System / Region | Approach | Substance | Qualifier |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | V Hormone | G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region | Approach | Substance | Qualifier |
| 5 Peripheral Artery 6 Central Artery | 0 Open 3 Percutaneous | W Immunotherapeutic | K Immunostimulator L Immunosuppressive |
| Body System / Region | Approach | Substance | Qualifier |
| 7 Coronary Artery 8 Heart | 0 Open 3 Percutaneous | 1 Thrombolytic | 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region | Approach | Substance | Qualifier |
| 7 Coronary Artery 8 Heart | 0 Open 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| 7 Coronary Artery 8 Heart | 0 Open 3 Percutaneous | K Other Diagnostic Substance P Platelet Inhibitor | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 7 Coronary Artery 8 Heart | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| 9 Nose | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| 9 Nose | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| 9 Nose | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| 9 Nose | 3 Percutaneous 7 Via Natural or Artificial Opening X External | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| A Bone Marrow | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| A Bone Marrow | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| B Ear | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| B Ear | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| B Ear | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 3 Anti-inflammatory B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| B Ear | 3 Percutaneous 7 Via Natural or Artificial Opening X External | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 3 Anti-inflammatory B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance M Pigment N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| C Eye | 3 Percutaneous 7 Via Natural or Artificial Opening X External | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| D Mouth and Pharynx | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| D Mouth and Pharynx | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| D Mouth and Pharynx | 3 Percutaneous 7 Via Natural or Artificial Opening X External | 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives R Antiarrhythmic T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| D Mouth and Pharynx | 3 Percutaneous 7 Via Natural or Artificial Opening X External | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| F Respiratory Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| F Respiratory Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| F Respiratory Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| F Respiratory Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| F Respiratory Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | S Gas | D Nitric Oxide F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| F Respiratory Tract | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| J Biliary and Pancreatic Tract | 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic | U Pancreatic Islet Cells | 0 Autologous 1 Nonautologous |
| Body System / Region | Approach | Substance | Qualifier |
| J Biliary and Pancreatic Tract | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 0 Open | 5 Adhesion Barrier | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 3 Percutaneous | 1 Thrombolytic | 7 Other Thrombolytic |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 3 Percutaneous | 3 Anti-inflammatory 5 Adhesion Barrier 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 3 Percutaneous | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 4 Percutaneous Endoscopic | 5 Adhesion Barrier | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 7 Via Natural or Artificial Opening | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| L Pleural Cavity | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 0 Open | 5 Adhesion Barrier | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody Y Hyperthermic |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 3 Percutaneous | 3 Anti-inflammatory 5 Adhesion Barrier 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 3 Percutaneous | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 4 Percutaneous Endoscopic | 5 Adhesion Barrier | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 7 Via Natural or Artificial Opening | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| M Peritoneal Cavity | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 0 Open | 5 Adhesion Barrier | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 3 Percutaneous | 3 Anti-inflammatory 5 Adhesion Barrier 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance L Sperm N Analgesics, Hypnotics, Sedatives T Destructive Agent V Hormone | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 3 Percutaneous | Q Fertilized Ovum | 0 Autologous 1 Nonautologous |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 3 Percutaneous | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 4 Percutaneous Endoscopic | 5 Adhesion Barrier | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 7 Via Natural or Artificial Opening | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 7 Via Natural or Artificial Opening | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 7 Via Natural or Artificial Opening | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance L Sperm N Analgesics, Hypnotics, Sedatives T Destructive Agent V Hormone | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 7 Via Natural or Artificial Opening | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 7 Via Natural or Artificial Opening | Q Fertilized Ovum | 0 Autologous 1 Nonautologous |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| P Female Reproductive | 8 Via Natural or Artificial Opening Endoscopic | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance A Stem Cells, Embryonic B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | E Stem Cells, Somatic | 0 Autologous 1 Nonautologous |
| Body System / Region | Approach | Substance | Qualifier |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| Q Cranial Cavity and Brain | 0 Open 3 Percutaneous | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| Q Cranial Cavity and Brain | 7 Via Natural or Artificial Opening | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| Q Cranial Cavity and Brain | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| R Spinal Canal | 0 Open | A Stem Cells, Embryonic | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| R Spinal Canal | 0 Open | E Stem Cells, Somatic | 0 Autologous 1 Nonautologous |
| Body System / Region | Approach | Substance | Qualifier |
| R Spinal Canal | 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| R Spinal Canal | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| R Spinal Canal | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance A Stem Cells, Embryonic B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| R Spinal Canal | 3 Percutaneous | E Stem Cells, Somatic | 0 Autologous 1 Nonautologous |
| Body System / Region | Approach | Substance | Qualifier |
| R Spinal Canal | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| R Spinal Canal | 3 Percutaneous | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| R Spinal Canal | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| S Epidural Space | 3 Percutaneous | 0 Antineoplastic | 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| S Epidural Space | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| S Epidural Space | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| S Epidural Space | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| S Epidural Space | 3 Percutaneous | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| S Epidural Space | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| T Peripheral Nerves and Plexi X Cranial Nerves | 3 Percutaneous | 3 Anti-inflammatory B Anesthetic Agent T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| T Peripheral Nerves and Plexi X Cranial Nerves | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| U Joints | 0 Open | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| U Joints | 0 Open | G Other Therapeutic Substance | B Recombinant Bone Morphogenetic Protein C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| U Joints | 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| U Joints | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| U Joints | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| U Joints | 3 Percutaneous | G Other Therapeutic Substance | B Recombinant Bone Morphogenetic Protein C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| U Joints | 3 Percutaneous | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| U Joints | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| V Bones | 0 Open | G Other Therapeutic Substance | B Recombinant Bone Morphogenetic Protein C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| V Bones | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| V Bones | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| V Bones | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| V Bones | 3 Percutaneous | G Other Therapeutic Substance | B Recombinant Bone Morphogenetic Protein C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| V Bones | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| W Lymphatics | 3 Percutaneous | 0 Antineoplastic | 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| W Lymphatics | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| W Lymphatics | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| W Lymphatics | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| Y Pericardial Cavity | 3 Percutaneous | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| Y Pericardial Cavity | 3 Percutaneous | 2 Anti-infective | 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region | Approach | Substance | Qualifier |
| Y Pericardial Cavity | 3 Percutaneous | 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Anesthetic Agent H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent | Z No Qualifier |
| Body System / Region | Approach | Substance | Qualifier |
| Y Pericardial Cavity | 3 Percutaneous | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| Y Pericardial Cavity | 3 Percutaneous | S Gas | F Other Gas |
| Body System / Region | Approach | Substance | Qualifier |
| Y Pericardial Cavity | 4 Percutaneous Endoscopic | G Other Therapeutic Substance | C Other Substance |
| Body System / Region | Approach | Substance | Qualifier |
| Y Pericardial Cavity | 7 Via Natural or Artificial Opening | 0 Antineoplastic | 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region | Approach | Substance | Qualifier |
| Y Pericardial Cavity | 7 Via Natural or Artificial Opening | S Gas | F Other Gas |
Additional Code Information includes:
Access to this feature is available in the following products:
|
ICD-10-PCS Index Entries (Reverse Index Lookup) 
reverse_index/reverse_index_content.php?set=ICD10PCS&c=3E0R3CZ
View historical information about the code including when it was added, changed, deleted, etc. Access to this feature is available in the following products:
|
Subscribers may add their own notes as well as "Admin Notes" visible to all subscribers in their account. Access to this feature is available in the following products:
Subscribers may add their own notes as well as "Admin Notes" visible to all subscribers in their account. |
Subscribers will see related documentation, coding and billing tips. Access to this feature is available in the following products:
|
View the general equivalency mappings (GEMs) between the ICD-9 and ICD-10 code sets. Access to this feature is available in the following products:
|
Cross-A-Code™ (ICD-9/10, CPT, Modifiers, NCCI, NDC, ASA CROSSWALK®)
crosswalks/crosswalk_content.php?set=ICD10PCS&c=3E0R3CZ
View relationships (or crosswalks) between code sets. Access to this feature is available in the following products:
|
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com
